Ratnakar Securities Pvt. Ltd.

TRIDENT LIFELINE LTD.

NSE : NABSE : 543616ISIN CODE : INE0MKA01014Industry : Pharmaceuticals & DrugsHouse : Private

BSE272.400 (0 %)

PREV CLOSE ( ) 272.40

OPEN PRICE ( ) 268.00

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 36000

TODAY'S LOW / HIGH ( )268.00 291.00

52 WK LOW / HIGH ( ) 194.5339

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 09-01 2014

Management Info

Hardik Jigishkumar Desai - Chairman Shravan Harikrishna Patel - Managing Director

Registered Office

Address 2nd Floor, Shop-2004, North Extension,Falsawadi Begumpura Nodh-4/1650,Sahara Darwaja,
Surat,
Gujarat-395003

Phone 0261 2451274 / 2451284

Email info@tridentlifeline.com

Website www.tridentlifeline.com

Registrars Details

MUFG Intime India Pvt Ltd.

5th Floor, 506 to 508,Amarnath Business Centre-1(Abc-1),,Beside Gala Business Center,Nr. St. Xavierâ€™s College, Corner, Off C G Road, Ellis Bridge,Ahmedabad

Listing : BSE

NEWS

12Jun Trident Lifeline informs about disclo
Trident Lifeline has informed that it enclosed the disclosure under Regu..

12Jun Trident Lifeline informs about disclos
Trident Lifeline has informed that the exchange has received the disclos..

12Jun Trident Lifeline informs about disclos
Trident Lifeline has ifnormed that the exchange has received the disclos..

09Jun Allotment of Convertible warrants
Inter alia, Considered and Approved Allotment of 9,94,200 Fully Conver..

13May Trident Lifelineâ€™s arm introduces ne
Trident Lifelineâ€™s subsidiary -- TLL Elements has successfully introdu..

Financials

in Millions

	QTR Dec 24	ANNUAL 25
Net Profit	30.27	130.51
Gross Profit	39.47	179.05
Operating Profit	46.77	206.62
Net Sales	165.09	677.99

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 35008.75 (5.62%)	M.Cap ( in Cr)74391.15
Onesource Specialty (BSE) 2194.45 (9.41%)	M.Cap ( in Cr)25119.00
Glaxosmithkline Phar (BSE) 3457.70 (4.86%)	M.Cap ( in Cr)58575.52
Astrazeneca Pharma I (BSE) 8896.30 (1.81%)	M.Cap ( in Cr)22240.75
Neuland Laboratories (BSE) 12118.80 (1.32%)	M.Cap ( in Cr)15548.29

Shareholding Pattern

	PROMOTERS	63.04%
	NON-INSTITUTION	30.25%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

attention investors
kyc
ipo
ibt trading
KYC & KRA Status Awareness

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

TRIDENT LIFELINE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES